Three new Ebola vaccines are being developed. An infectious disease expert explains
New funding has been secured to develop three vaccine candidates targeting the Bundibugyo Ebola virus currently circulating in the DRC and Uganda. Experts note that existing vaccines are ineffective against this specific strain, necessitating new research.
Why it matters
Addressing the specific strain of Ebola in Central Africa is critical for public health, as current vaccines do not provide cross-protection against all virus variants.
Dieudonne Dirole/EPA Three new Ebola vaccines are being developed. An infectious disease expert explains Published: June 4, 2026 4:08pm EDT https://theconversation.com/three-new-ebola-vaccines-are-being-developed-an-infectious-disease-expert-explains-284290 https://theconversation.com/three-new-ebola-vaccines-are-being-developed-an-infectious-disease-expert-explains-284290 Link copied Share article Share article
The article provides scientific and public health information based on expert analysis and reported data.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in